Entries from 2016-08-24 to 1 day
The global hepatitis drugs market was valued at $23,222.1 million in 2014, and it is expected to grow with a CAGR of 29.7% during 2015 - 2020. The global hepatitis drugs market is growing due to increasing incidences of hepatitis and incre…